Sensitivity to light and noise in tension-type and cervicogenic headache by Drummond, P.D.
Cephalalgia 1998;18:303-5.  Oslo. ISSN 0333-1024 
Editorial  Commentary 
Sensitivity  to  light  and 
noise  in tension-type 
and  cervicogenic 
headache 
Attempts  to  identify  discrete  sets  of 
symptoms  which  define  clinically 
recognized  headache  syndromes  in 
the  migraine-tension  headache  spec- 
trum  have  largely  met  with  failure, 
primarily  because  many  patients 
describe  features  of  both  types  of 
headache  (1).  The  substantial  overlap 
of  clinical  symptomatology  suggests 
that  similar  mechanisms  are  active 
during  different  fypes  of  headache, 
perhaps  developing  secondarily  in 
response  to  a  primary  pathophysio- 
logical  process. 
In  this  issue  of  CephaZaZgia,  Vana- 
gaite  Vingen  and  Stovner  report  that 
patients  with  tension-type  or  cervi- 
cogenic  headache  were  more  sensi- 
tive  to  light  and  sound  than 
headache-free  controls,  even  when 
patients  were  tested  during  the 
headache-free  interval.  In  a  series 
of  related  studies,  Vanagaite  Vingen 
and  colleagues  reported  similar  find- 
ings  for patients  with  migraine  (2,3). 
In  addition,  patients  with  cluster 
headaches  were  unusually  sensitive 
to  light  and  sound  during  bouts  but 
not  during  the  remission  period 
between  bouts  (4).  Painful  stimula- 
tion  of  the  head  intensifies  visual 
discomfort  in  migraine  sufferers  but 
not  controls  (5,  6),  suggesting  that 
mechanisms  that  normally  suppress 
photophobia  are  disrupted  during 
the  headache-free  interval  as  well 
as  during  migraine.  The  persistence 
of  phonophobia  in  various  forms  of 
headache  implies  that  a  similar 
process  modiies  sensitivity  to 
sound;  however,  experimental  evi- 
dence  to  support  this  view  is lacking 
(5). 
The  message  to  come  from  the 
series  of papers  by  Vanagaite  Vingen 
and  colleagues  is  that  symptoms 
such  as  photophobia  and  phonopho- 
bia  are  not  specific  enough  to  be 
useful  for  differential  diagnosis  of 
headache  syndromes.  This  point  is 
particularly  important  for  tightening 
the  diagnostic  criteria  for  cervico- 
genie  headache,  where  many  of  the 
symptoms  may  arise  because  of 
convergence  of  pain  impulses  on  a 
“final  common  pathway”  that  is 
active  during  other  forms  of  head- 
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QEEG  in migraine 
without  aura 
De  Tommaso  and  co-workers  pro- 
vide  interesting  data  on  spontaneous 
and  visually  evoked  EEG  in migraine 
without  aura  (this  issue).  Most 
importantly,  they  recorded  EEG  both 
during  headache  and  in  a  pain-free 
phase.  Using  blinded  data  analysis, 
the  authors  found  consistent  changes 
in  brain  electrical  activity  during 
headache,  i.e.,  slowing  and  asymme- 
try  of  the  posterior  alpha  peak 
frequency.  In  addition,  they 
observed  increased  left  temporal 
theta  power  during  pain  (the  major- 
ity had  left-sided  symptoms).  A large 
proportion  (14  of  16  patients)  had 
slowing  outside  the  control  group 
range,  thus  EEG  spectral  analysis 
(QEEG)  during  headache  can  possi- 
bly  be  used  as  a marker  of  migraine. 
It remains  for  this  to be  confirmed  in 
studies  with  larger  control  and 
patient  groups. 
The  authors  found  reduction  (nor- 
malization)  of  photic  driving  ampli- 
tude  during  headache.  Both 
background  EEG  frequency  slowing 
and  visually  evoked  EEG  power 
reduction  can  reflect  cortical  inhibi- 
tion  in  the  late  headache  phase, 
while  increased  theta  power  tenta- 
tively  suggests  that  a  different  pat- 
tern  of  reactivity  is  found  in  the 
temporal  lobe.  Whether  this  pre- 
sumed  cortical  inhibition  was  trig- 
gered  by  a wave  of depolarization,  as 
suggested  by  the  authors,  or  by 
another  (e.g.,  vascular)  process  can- 
not  definitely  be  answered  by  EEG 
studies  alone.  It should  be noted  that 
these  results  do  not  necessarily 
imply  that  synaptic  inhibition  is 
excessive. 
QEEG  is  certainly  more  objective 
than  conventional  EEG  interpreta- 
tion.  Still,  a  number  of  possible 
pitfalls  have  to  be  avoided,  e.g., 
epoch  selection  bias,  state  fluctua- 
tions,  non-cerebral  electrical  genera- 
tors,  and  electrode  artifacts.  The 
method  is  mainly  useful  in  research, 
and  it  is  generally  recommended  to 
use  QEEG  only  in  conjunction  with 
visual  EEG  interpretation  performed 
by  a  skilled  physician  (1). 
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.  Endothelin  in  migraine 
patients 
In  1991,  Edmeads  suggested  the 
involvement  of  the  endothelial 
derived  constricting  factor,  endo- 
thelin,  and  its  endothelial  counter- 
part,  nitric  oxide  (NO),  respectively, 
in  the  pathophYsiology  of  vascular 
changes  (vasoconstric  tion  and  sub- 
sequent  vasodilation)  during  mi- 
graine  attacks  (1). 
American 
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The  first  demonstration  of 
increased  levels  of  ET-l  during 
migraine  attacks  by  Fakkila  et  al. 
(2)  was  confirmed  successively  by 
our  group  (3)  both  in  migraine 
patients  with  and  without  aura  (3). 
In  our  study  the  significant  rise  of 
this  vasoconstrictive  peptide  in 
plasma  persisted  also  between  4 
and  6  h  from  the  onset  of  attacks. 
In  the  present  research,  a  rise  of 
endothehn  in plasma  was  also  found 
ictally,  with  the  highest  values  occur- 
ring  in  the  first  2  h  after  the  start  of 
the  migraine  attack.  Unlike  our 
study,  the  values  of  ET-l  fell  3 -4  h 
after  the  beginning  of  attacks,  even 
to  values  lower  than  those  measured 
inter&ally. 
Several  factors  putatively  involved 
in  the  early  events  of  the  migraine 
attack increase  the production  of endo- 
thelin,  such  as  serotonin,  nore- 
pinephrme,  hypoxia,  arachidonic 
acid  and  its  by-products  or  by- 
products  of  cyclooxy-genase  activity. 
On  the  other  hand,  the  higher  levels 
of  endothelin  might  be  the  conse- 
quence  of hemodynamic  shear  stress 
in  the  vasodilatory  phase.  This  may 
represent  a  physiological  vaso- 
constricting  mechanism  counter- 
balancing  the  abnormal  vasodilation 
due  to  the  production  of  sensory 
neuropeptides  by  trigeminovascular 
activation,  or  to  the  local  release  of 
prostacyclin  and  NO.  However, 
endothelin  itself can  stimulate  the NO. 
A  role  for  ET-1  in  mediating 
neurogenic  inflammation  has  been 
proposed  (4).  However,  the  endothe- 
lin  antagonist  bosentan  that  blocks 
expression  of  neurogenic  inflamma- 
tion  was  not  effective  in  aborting 
migraine  attacks  (5).  The  mode  of 
action  of  the  5HT-agonists  might 
suggest  that  they  could  also  exercise 
their  vasoconstrictive  action  by  block- 
ing endothelm  production  and  release. 
In  light  of  this,  ET-1  could  be  con- 
sidered  a  “natural  migraine  com- 
pound’. 
This is the  first attempt  to study  the 
effect  of 5HT  abortive  migraine  drugs 
on  ET-l,  although  results  are  not 
conclusive.  A  definite  answer  regard- 
ing  the  source  of  the  ET-l  rise  during 
migraine  attacks  could  be  obtained  if 
blood  samples  were  drawn  from  the 
jugular  blood.  Further  research  is  also 
needed  to  investigate  the  sequential 
production  of  vasoactive  substances 
with  vasoconstricting  effects  (primar- 
ily endothelin)  and  vasodilatmg  effects 
(trigerninovascular  neuropeptides, 
NO,  prostacyclin)  and  the  relation- 
ships  between  their  peripheral  and 
jugular  venous  blood  levels  to  hen-to 
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MiPraine  in  childhood 
ana  adolescence 
In  this  issue  of  Cephalalgia, Gherpelli 
and  co-workers  report  a  study  on 
headache  in children  and  adolescents 
~15  years  of  age.  The  study  focuses 
on  migraine  and  reports  two  major 
findings;  on  the  one  hand  the  rela- 
tionship  between  age  and  migraine 
type,  headache  characteristics,  and 
associated  symptoms  of  the  Interna- 
tional  Headache  Society  (B-IS) classi- 
fication,  on  the  other  the  sensitivity 
and  specificity  of  the  IHS  criteria  of 
migraine  without  aura.  Similar  to 
earlier  reports,  the  prevalence  of 
aura,  pulsating  quality,  and  unilat- 
eral  location  was  higher  in  older 
children.  Sensitivity  was  >70%  for 
duration,  pain  intensity,  aggravation 
with  physical  activity,  photophobia, 
and  phonophobia.  Specificity  was 
>70%  for  aggravation  with  physical 
activity  and  all  concomitant 
symptoms.  Even  though  duration  of 
2 -48  h  5HT  had  a  good  sensitivity, 
almost  60%  of  children  with  a 
migrainous  disorder  (MS  1.7)  had  a 
headache  duration  of  ~2  h.  Accord- 
ingly,  Gherpelli  and  co-workers 
CEPHALALGIA  18 (1998) 
propose  to  withdraw  the  duration 
criterion  of  migraine  without  aura 
completely. 
Since  1988,  the  MS  criteria  have 
been  applied  in  a  series  of  popula- 
tion-  and  clinic-based  studies  on 
headache  in  childhood.  The  majority 
of  these  studies  have  focused  on 
migraine  and  only  a  few  have 
included  tension-type  or  other  head- 
aches.  In  total,  the  studies  comprise 
more  than  1,800  (range  25 -395) 
children  suffering  from  migraine. 
The  studies  were  performed  in 
several  European  countries,  in 
Canada  and  in  the  United  States. 
The  work  by  Gherpelli  et  al.  adds 
important  data  from  a  South  Amer- 
ican  country,  Brazil. 
Including  the  authors  of  the 
current  paper,  eight  research  groups 
(l-8)  have  made  specific  proposals 
regarding  a  forthcoming  revision  of 
the  current  IHS  criteria  for  migraine 
in  childhood.  Seven  of  the  eight 
groups  have  proposed  a  reduction 
in  the  required  minimum  duration 
of  childhood  migraine  from  2  to  1 
h.  Four  groups  have  proposed 
changes  to  the  unilaterality  criter- 
ion,  reflecting  the  observation  that 
many  children  suffering  from 
migraine  give  a  bilateral  fronto/ 
temporal  or  median  frontal  location. 
Another  four  groups  have  proposed 
revisions  of  the  photophobia/pho- 
nophobia  criterion.  Single  proposals 
include  revising  the  minimum  num- 
ber  of  attacks,  intensity,  aggravation 
with  physical  activity,  and  nausea. 
None  of  the  groups  have  suggested 
revisions  of  quality,  vomiting  or 
aura. 
The  literature  on  the  IHS  criteria 
for  childhood  migraine  is enriched  by 
this  well-written  paper  by  Gherpelli 
and  co-workers.  The  international 
ChildhOOd  headache  community 
would  appreciate  hearing  more  from 
our  Brazilian  colleagues,  and  other 
researchers  throughout  the  world. 
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